Advancing molecular diagnostics for Acute Leukemia

Molecular diagnostics is a fast evolving field with new innovative platforms and assays that continually improve medical care of patients. This talk will cover changes to current standard of care practices in CBF-AML, new and exciting advances in molecular diagnostics for acute leukemia, and how our work will impact your leukemia patients in the future. After viewing this lecture, participants should be able to:
1. Apply current standard of care practices in CBF-AML
2. Discuss new and exciting advances in molecular diagnostics for acute leukemia in low resource settings
3. Utilize new diagnostic tools to impact leukemia patients in the future

Cecilia CS Yeung, MD
Associate Professor - Fred Hutchinson Cancer Research Center, Clinical Research Division
Associate Professor - University of Washington, Dept. of Laboratory Medicine and Pathology
Medical Director - Fred Hutch CLIA Laboratories, Fred Hutchinson Cancer Research Center
Pathologist - Seattle Cancer Care Alliance